80 related articles for article (PubMed ID: 18950629)
1. Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells.
Bosier B; Lambert DM; Hermans E
FEBS Lett; 2008 Nov; 582(28):3861-7. PubMed ID: 18950629
[TBL] [Abstract][Full Text] [Related]
2. Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression.
Bosier B; Hermans E; Lambert DM
Biochem Pharmacol; 2009 Jan; 77(2):216-27. PubMed ID: 18992715
[TBL] [Abstract][Full Text] [Related]
3. Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line.
Bosier B; Tilleux S; Najimi M; Lambert DM; Hermans E
J Neurochem; 2007 Sep; 102(6):1996-2007. PubMed ID: 17540007
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor.
Bosier B; Hermans E; Lambert D
Br J Pharmacol; 2008 Sep; 155(1):24-33. PubMed ID: 18536748
[TBL] [Abstract][Full Text] [Related]
5. ERK signalling pathway is not involved in PSA-NCAM-dependent alterations of hippocampal plasticity evoked by CB1 receptor activation.
Maćkowiak M; Dudys D; Wedzony K
Pharmacol Rep; 2009; 61(6):1008-16. PubMed ID: 20081235
[TBL] [Abstract][Full Text] [Related]
6. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Shinagawa K; Teshima T; Ishimaru F; Ikeda K; Tanimoto M
Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
[TBL] [Abstract][Full Text] [Related]
7. CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells.
Zhou D; Song ZH
J Neurosci Res; 2001 Aug; 65(4):346-53. PubMed ID: 11494371
[TBL] [Abstract][Full Text] [Related]
8. Analysis of signal transduction pathways during anoxia exposure in a marine snail: a role for p38 MAP kinase and downstream signaling cascades.
Larade K; Storey KB
Comp Biochem Physiol B Biochem Mol Biol; 2006 Jan; 143(1):85-91. PubMed ID: 16326124
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells.
Blume LC; Eldeeb K; Bass CE; Selley DE; Howlett AC
Cell Signal; 2015 Mar; 27(3):716-726. PubMed ID: 25446256
[TBL] [Abstract][Full Text] [Related]
10. Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell.
Korzh A; Keren O; Gafni M; Bar-Josef H; Sarne Y
Brain Res; 2008 Jan; 1189():23-32. PubMed ID: 18068691
[TBL] [Abstract][Full Text] [Related]
11. Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo.
Bosier B; Muccioli GG; Mertens B; Sarre S; Michotte Y; Lambert DM; Hermans E
Neuropharmacology; 2012 Jun; 62(7):2328-36. PubMed ID: 22365976
[TBL] [Abstract][Full Text] [Related]
12. Exocannabinoids effect on in vitro bovine oocyte maturation via activation of AKT and ERK1/2.
López-Cardona AP; Sánchez-Calabuig MJ; Beltran-Breña P; Agirregoitia N; Rizos D; Agirregoitia E; Gutierrez-Adán A
Reproduction; 2016 Dec; 152(6):603-612. PubMed ID: 27798282
[TBL] [Abstract][Full Text] [Related]
13. PTH regulation of c-Jun terminal kinase and p38 MAPK cascades in intestinal cells from young and aged rats.
Buzzi N; Boland R; de Boland AR
Biogerontology; 2007 Apr; 8(2):189-99. PubMed ID: 17120084
[TBL] [Abstract][Full Text] [Related]
14. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
15. Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx.
Garavello W; Nicolini G; Aguzzi A; Maggioni D; Leone BE; Viganò P; Gaini RM; Tredici G
Oncol Rep; 2006 Sep; 16(3):479-84. PubMed ID: 16865246
[TBL] [Abstract][Full Text] [Related]
16. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
17. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
[TBL] [Abstract][Full Text] [Related]
18. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells.
Greenhough A; Patsos HA; Williams AC; Paraskeva C
Int J Cancer; 2007 Nov; 121(10):2172-80. PubMed ID: 17583570
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of three mitogen-activated protein kinases on lipoprotein (a)-induced human mesangial cell proliferation.
Song HM; Wei M; Xu K; Li XW
Chin Med J (Engl); 2010 Jan; 123(2):216-20. PubMed ID: 20137374
[TBL] [Abstract][Full Text] [Related]
20. Differential role for mitogen-activated protein kinases in IgE-dependent signaling in human peripheral blood basophils: in contrast to p38 MAPK, c-Jun N-terminal kinase is poorly expressed and does not appear to control mediator release.
Gibbs BF; Wolff HH; Zillikens D; Grabbe J
Int Arch Allergy Immunol; 2005 Apr; 136(4):329-39. PubMed ID: 15741731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
